Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1998
11/17/1998US5837279 Encapsulation of ionizable agents in liposomes
11/17/1998US5837276 Apparatus for the delivery of elongate solid drug compositions
11/17/1998US5837268 Immunogens; genetic engineering; noncytotoxic; antitumor agents for breast cancer
11/17/1998US5837264 Potentiation of immunogenic response
11/17/1998US5837250 Controlling immune response; antigen complex
11/17/1998US5837228 Drug delivery device for controlled release of drugs
11/17/1998US5837226 Ocular microsphere delivery system
11/16/1998CA2205692A1 Method of administration for a therapeutic agent utilizing suitable forms of hyaluronic acid and combinations with electroporation
11/15/1998CA2237450A1 Preparation having increased in vivo tolerability
11/12/1998WO1998050582A1 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES
11/12/1998WO1998050435A1 Immunotoxins, comprising an onc protein, directed against malignant cells
11/12/1998WO1998050432A1 Recombinant antibody-enzyme fusion proteins
11/12/1998WO1998050078A1 Lipophilic and/or lytic peptides for specific delivery of nucleic acids to cells
11/12/1998WO1998050077A1 Solid pharmaceutical formulations containing a physical mixture of sulfoalkyl ether cyclodextrin and a therapeutic agent
11/12/1998WO1998050058A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998WO1998050039A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure erectile dysfunction
11/12/1998WO1998050019A1 Stable oral pharmaceutical dosage forms
11/12/1998WO1998050018A1 Drug delivery system
11/12/1998WO1998050017A1 Poly(vinyl alcohol) cryogel
11/12/1998WO1998050015A1 Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
11/12/1998WO1998050005A1 Compositions for cosmetic applications
11/12/1998WO1998050004A1 Ascorbyl-phosphoryl-cholesterol
11/12/1998WO1998036074A3 Single and double chain antibodies to the egf receptor, derivates thereof and their use
11/12/1998WO1998029540A3 RECOMBINANT FUSION PROTEINS BASED ON RIBOSOME-INACTIVATING PROTEINS OF EUROPEAN MISTLETOE $i(VISCUM ALBUM)
11/12/1998WO1998027966A3 Encapsulated cells producing antibodies
11/12/1998CA2299455A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998CA2289115A1 Recombinant antibody-enzyme fusion proteins
11/12/1998CA2288876A1 Drug delivery system
11/12/1998CA2288806A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998CA2288232A1 Immunotoxins directed against malignant cells
11/11/1998EP0876819A1 Use of copolymers of n-vinylpyrrolidone in the preparation of water insoluble compositions
11/11/1998EP0876816A1 Capsule containing whey protein
11/11/1998EP0876814A1 Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
11/11/1998EP0876611A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same
11/11/1998EP0876165A1 Crosslinked polymer compositions and methods for their use
11/11/1998EP0876160A2 Ligand directed enzyme prodrug therapy
11/11/1998EP0876159A1 Composition for treating skin affections and process for its preparation
11/11/1998EP0876155A1 Highly concentrated, lyophilized, and liquid factor ix formulations
11/11/1998EP0876145A1 Taxane composition and method
11/11/1998EP0876141A2 Preparations of non-steroidal analgesics
11/11/1998EP0876140A2 Improved concentrated injection and infusion solutions for intravenous administration
11/11/1998EP0876131A1 Drug delivery compositions for improved stability of steroids
11/11/1998EP0876109A1 Water dispersible compositions containing natural hydrophobic pigment, method of preparing same and their use
11/11/1998EP0796080B1 Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss
11/11/1998EP0776197B1 Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives
11/11/1998EP0766570A4 Methods for treating respiratory disease
11/11/1998EP0744940B1 Drugs, vaccines and hormones in polylactide coated microspheres
11/11/1998EP0720473B1 Budesonide pellets with a controlled release pattern and process for producing them
11/11/1998EP0693921A4 Anti-oxidant alkylaryl polyether alcohol polymers
11/11/1998EP0632720B1 Hydroxyethylcellulose-based sustained-release oral drug dosage froms
11/11/1998EP0586381B1 Improved blood substitute
11/11/1998CN1198816A Polyoxyhydrocarbyl related products and methods for fluorescence assays
11/11/1998CN1198677A Isotopic urea tablets
11/11/1998CN1198672A Gel for the local hormonotherapy of vaginal dryness
11/11/1998CN1198670A Photostable aqueous solution containing benzyl alcohol derivatives
11/11/1998CN1198665A Unit galenical form for local hormonotherapy of vaginal dryness
11/11/1998CN1198441A The use of copolymers of N-vinylpyrrolidone in preparations of water-insoluble substances
11/11/1998CN1198323A Microstructure composition
11/10/1998US5834607 For enhanced cellular uptake of oligonucleotides; antisense therapy
11/10/1998US5834599 Monoclonal antibodies which bind to an epitope of gp120, conjugated to a cytotoxic agent, anti-viral agent, or an agent to facilitate passage through the blood-brain barrier; inhibit t-cell infection, syncytium formation; immunotoxins
11/10/1998US5834598 Having variations in amino acids ten, fourteen, eighteen and twenty-one
11/10/1998US5834596 Process for purifying ApoA or ApoE
11/10/1998US5834594 Polyethylene-protein conjugates
11/10/1998US5834519 Stabilized gas-supersaturated emulsions and suspensions
11/10/1998US5834510 Topical application
11/10/1998US5834448 Dosage form of hydroxocobalamin and its use in cyanide poisoning
11/10/1998US5834445 Providing a suitable pastel cosmetic color by combining an aqueous solution of a cyclodextrin, a topical carrier,an antioxidant and an organic solution of b-carotene; skin creams
11/10/1998US5834444 Hyaluronic acid and salts thereof inhibit arterial restenosis
11/10/1998US5834441 Introducing a genetic sequence into a host cell
11/10/1998US5834432 Use of angiotensin II Type 2 receptor agonists in tissue repair
11/10/1998US5834266 Regulated apoptosis
11/10/1998US5834232 Cross-linked gelatin gels and methods of making them
11/10/1998US5834045 Calcium fortified beverages
11/10/1998US5834028 Storage stable solutions with maltose, lactose or sucrose and arginine hydrochloride; for treatment or prevention of blood coagulation disorders
11/10/1998US5834023 Diltiazem controlled release formulation
11/10/1998US5834022 Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
11/10/1998US5834020 Diagnostic imaging
11/10/1998US5834017 Oral cyclopsporin formulations
11/10/1998US5834014 Modifying minoxidil with alpha-hydroxy acid to make it more hydrophilic, encapsulating in a lipid vesicle of glycerol dilaurate; improved penetration for topical delivery
11/10/1998US5834010 Triacetin as a penetration enhancer for transdermal delivery of a basic drug
11/10/1998US5834003 Topically applying chlorine dioxide activated and stabilized by a sodium phosphate; bactericides; fungicides; viricides
11/10/1998US5834001 Methods for making immunoisolatory implantable vehicles with a biocompatiable jacket and a biocompatible matrix core
11/10/1998US5833988 Noninvasive drug delivery across the blood-brain barrier by administering a conjugate of an antibody, and either a nerve growth factor or neurotrophic factor; treating alzheimer's disease, stroke, epilepsy, parkinson's disease
11/10/1998US5833985 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity
11/10/1998US5833967 Colloidal silica as a reinforcing agent of keratin substances
11/10/1998US5833665 Polyurethane-biopolymer composite
11/10/1998US5833647 Mixing drug within gel with magnetic dipoles, applying oscillating magnetic field to agitate magnetic dipoles
11/10/1998CA1340120C Hydroxyacids for topical treatment of wrinkles and skin changes associated with aging
11/05/1998WO1998049348A1 Oligonucleotides for enhanced bioavailability
11/05/1998WO1998049198A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/05/1998WO1998049191A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
11/05/1998WO1998049182A2 Gggg or gtgt as carriers for drug delivery
11/05/1998WO1998049175A1 Method for producing carbohydrate partial esters
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998049142A1 Dna-binding pyrrole and imidazole polyamide derivatives
11/05/1998WO1998049135A1 Compounds and compositions for delivering active agents
11/05/1998WO1998048859A1 Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same
11/05/1998WO1998048840A1 Polyethylene glycol-interferon alpha conjugates for therapy of infection
11/05/1998WO1998048837A1 Polyalkylene oxide-modified single chain polypeptides
11/05/1998WO1998048836A1 Anti-helicobacter vaccine composition comprising a th1 adjuvant
1 ... 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 ... 1712